Affiliated Hospital of Jiangnan University
Wuxi, Jiangsu, 214000, China
NCT Number: NCT05681234
This is a single arm study to evaluate the safety and biodistribution of 18F-labeled RD2 PET/CT Imaging in patients with small liver carcinoma.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Wuxi, Jiangsu, 214000, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients will receive 5-10 mCi 18F-RD2
Time frame: 2 hours
Biodistribution of 18F-RD2 evaluated by radioactive uptake values (standardized uptake values, SUVs) in various organs during repeated 18F-RD2 scans will be reported.
Affiliated Hospital of Jiangnan University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02305459
Adenocarcinoma, Carcinoma
Vienna, Austria
View Trial DetailsNCT04288323
Adenocarcinoma, Carcinoma
La Jolla, California, United States
View Trial DetailsNCT06720675
Adenocarcinoma, Carcinoma
Bologna, Italy
View Trial DetailsNCT06789224
Abdominal Neoplasms, Adenocarcinoma
Cologne, North Rhine-Westphalia, Germany
View Trial Details